Hematologic Oncology Update cover image

Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting

Hematologic Oncology Update

00:00

Do You Have a Molecular Response in Pv?

There is now a quite significant incentive for those that are providing the guidelines to perhaps incorporate molecular monitoring in everyday management of et and pv patients. That will require a lot uh from the involved providers to think about molecular response have a test available and then interpret it. I would worry if we up the bar and say you should monitor for molecular response and only minority have a molecular response then I would worry that the doctor or a patient particularly patient would say I know my numbers are are excellent and my trombotic risk blood clotting risk is controlled well by having a good blood count  I'm not responding because I don't have a molecularresponse I want something else, he says.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app